Gijs van den Brink

Dr. Gijs van den Brink is a distinguished physician scientist known for his dedication to translating scientific breakthroughs into practical solutions that advance life quality and longevity.

With a strong educational background, Gijs studied at Murmellius and obtained degrees in Gastroenterology & Hepatology from Leiden University and the University of Geneva. He also pursued studies in Internal Medicine, earning a Doctor of Philosophy (PhD) in Medicine, cum laude, and an MD degree from the University of Amsterdam.

Throughout his career, Gijs held notable roles like Senior Vice President & Global Head of Immunology, Infectious Diseases, and Ophthalmology Discovery at Roche. Previously, he served as a Professor of Experimental Gastroenterology at the Tytgat Institute for Liver and Intestinal Research at the Academic Medical Center.

Gijs van den Brink has also been associated with GlaxoSmithKline Pharma GmbH, where he was the Senior Vice President & Global Head of ImmunoInflammation and Respiratory Medicine Discovery Units. His contributions extend to the European Federation of Pharmaceutical Industries and Associations (EFPIA) as an Innovation Board Member.

Noteworthy affiliations in Gijs's career include positions at prestigious institutions like the European Crohn's and Colitis Organisation and the United European Gastroenterology (UEG) where he was involved in various roles such as Course Director and Member of Postgraduate Course Committee.

Dr. van den Brink's professional journey has included roles as a Gastroenterologist at the Academic Medical Center and Leiden University Medical Center (LUMC). He also served as a Visiting Scientist at Harvard Medical School and completed a research internship at Tufts Medical Center.

Known for his values of kindness, honesty, and transparency in leadership, Gijs prides himself on leading talented teams to transform innovative scientific concepts into impactful therapeutic solutions for individuals affected by various diseases.